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Background: The importance of strong science, technology, engineering, and mathematics education continues to
grow as society, medicine, and the economy become increasingly focused and dependent upon bioscientific and
technological innovation. New advances in frontier sciences (e.g., genetics, neuroscience, bio-engineering,
nanoscience, cyberscience) generate ethical issues and questions regarding the use of novel technologies in
medicine and public life.
Discussion: In light of current emphasis upon science, technology, engineering, and mathematics education (at the
pre-collegiate, undergraduate, graduate, and professional levels), the pace and extent of advancements in science
and biotechnology, the increasingly technological orientation and capabilities of medicine, and the ways that
medicine – as profession and practice – can engage such scientific and technological power upon the multi-
cultural world-stage to affect the human predicament, human condition, and perhaps nature of the human being,
we argue that it is critical that science, technology, engineering, and mathematics education go beyond technical
understanding and directly address ethical, legal, social, and public policy implications of new innovations. Toward
this end, we propose a paradigm of integrative science, technology, ethics, and policy studies that meets these
needs through early and continued educational exposure that expands extant curricula of science, technology,
engineering, and mathematics programs from the high school through collegiate, graduate, medical, and post-
graduate medical education. We posit a synthetic approach that elucidates the historical, current, and potential
interaction of scientific and biotechnological development in addition to the ethico-legal and social issues that are
important to educate and sustain the next generation of medical and biomedical professionals who can appreciate,
articulate, and address the realities of scientific and biotechnological progress given the shifting architectonics of
the global social milieu.
Summary: We assert that current trends in science, technology, medicine, and global politics dictate that these
skills will be necessary to responsibly guide ethically sound employment of science, technology, and engineering
advancements in medicine so as to enable more competent and humanitarian practice within an increasingly
pluralistic world culture.
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Scientific knowledge and technological tools have enabled
the heuristics and advancements that have led to rapid
progress in several fields (e.g., genomics, the neurosciences,
bio-engineering, nanotechnology, cyberscience) that are
constituent to the profession and practices of modern
medicine. Indeed, much of the current scope, tenor, and
capability of medicine have been expanded, if not defined,
by scientific and technological capabilities [1]. Yet, medi-
cine remains a deeply humanitarian discipline, character-
ized by its fundamental philosophical tenets of providing
both (technically) right and (morally and ethically) good
care to those rendered vulnerable by the predicament of
injury, disease, and the infirmities of life [2]. However, the
pace and profundity of such innovation and developments
often exceed the extent, if not capability, of the ethical
approaches and deliberation necessary both to address the
issues that such biosciences and technology may generate,
and to inform the guidelines, policies, and laws that guide
and govern research and its applications in various
domains within medicine (if not the social realm at large).
Moreover, given the leverage that bioscience and technol-
ogy confer and elicit upon an increasingly pluralist world
stage, any such ethics, guidelines, and policies will need to
be articulated in culturally sensitive ways, so as to best
reflect the dynamics of what has been termed the contem-
porary “global shift” [3]. In light of this, we posit that
education that is singularly focused upon either the
sciences or the humanities will not be sufficiently deep or
broad to prepare future practitioners and leaders to engage
the challenges evoked by an ever-expanding capability of
science and technology in medicine and/or society [4,5].
Discussion
If we are to prioritize science, technology, engineering,
and mathematics (i.e., STEM) pursuant to medical and
biomedical education, training, and practice, then it is
essential to do so in ways that genuinely appreciate and
apprehend these pursuits as human enterprises that are
devised and articulated, and impact the boundaries of
human culture and its societies. In other words, we must
ground STEM education to the reality that STEM – as
contributory to medicine, and like medicine itself – are
human endeavors for and within the sphere of humanity,
human conduct, and human ecology. We opine that to
meet the opportunities, benefits, challenges, and burdens
generated by the study, development, and use of STEM in
real-world scenarios, education must not only be multi-
disciplinary, but must engage the natural, physical, and
social sciences as well as the humanities in an integrative
model that 1) obtains a solid foundation in humanitarian
sensitivities, 2) engages knowledge of STEM to address the
challenges of modern medicine enacted on a global scale,
and 3) entails the humanities and social sciences to assessand direct the value and utility of STEM (as constituents of
medical practice) within current culture, and as means to
shape health, culture, and societies of the future.
Fortification of STEM education is important if we are
to train medical and biomedical professionals to possess
the knowledge, skills, and innovative acumen that will be
required to keep pace with – and within – the worldwide
groundswell of scientific and technological (S/T) progress.
To be sure, S/T advancement requires significant economic
support, and in turn, can elicit tremendous economic
growth. Much of S/T research is conducted by, and subsi-
dized through, the infrastructure of the so-called “triple
helix” of academic, government, and commercial research
institutions [6]. For example, a number of biotechnology
companies have been developed and have evidenced
sustained growth around prestigious universities (e.g.,
Silicon Valley near Stanford University; the venture
capital enclave around Harvard, MIT, Northeastern, Tufts,
and other academic institutions of Cambridge/Boston in
the United States); these S/T nodes have been important to
transferring knowledge from academic laboratories to the
marketplace, and commercializing the outcomes, products,
and tangible benefits of academic research in the corporate
and public spheres including medicine. Moreover, such
focal centers of triple helix activity are serving as a model
for rapid S/T progress and are arising in other countries as
well (e.g., the corporate-academic complexes of Munich
and other cities in Germany; multiple sites in China and
India, etc.). Thus, academic training in STEM has exerted,
and will continue to exert, a direct effect upon industrial
development and economic growth in the United States [6]
and abroad.
On many levels, the triple helix model provides a
viable framework for STEM education and training [7].
As hybrid fields develop through the strategic conjoinment
of heretofore traditionally siloed scientific disciplines,
advances spawned by integrative scientific convergence will
both increase currently known and recognized technical,
ethical, legal, and social challenges, and will foster other
challenges that will be somewhat more unique given the
novelty of methods, tools, outcomes, and effects [8]. To
intuit, work, and succeed in the interdisciplinary environ-
ment of integrative scientific convergence within the triple
helix, students and biomedical professionals must
understand and be relatively fluent in epistemologies
and human dynamics of academia, government, and indus-
try. We assert that this will require a deeper and broader
educational design that develops genuinely equivalent
competencies in the sciences and humanities [7-9].
Ethics and policy studies: “In-STEP” with STEM Education
for – and in – medicine
Toward this end, we have proposed a model of inte-
grative science, technology, ethics, and policy studies
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through which to build competencies in the content,
constructs, and applications of convergent sciences, as well
as the knowledge and skill sets necessary to realistically
observe, and meaningfully address and guide, the conduct
and uses of science and technology as human enterprises
[8,9]. The overarching goals of the In-STEPS paradigm are
to integrate scientific and humanitarian disciplines at all
levels from high school through undergraduate, graduate,
medical and post-graduate medical education. This will 1)
provide an early exposure to issues and social implications
of scientific and technological research and applications; 2)
generate a deep understanding of specific ethical, legal, and
policy issues that are relevant to those ways that frontier
domains of science and technology can be used or misused
in medicine to alter the human condition, human predica-
ment, and various aspects of social action; and 3) develop
insights and capabilities to enable more thorough and valid
deliberation and direction of the ways that science and
technology should be employed within clinical care to
sustain the values and goods of individuals, communities,
and societies [8,9].
We maintain that integrating studies of ethical, legal,
and social issues (ELSI) within the fabric of STEM-based
pre-medical and medical education will be important to
developing the abilities to responsibly (and arguably more
effectively) work in and lead science, biotechnology, and
medicine as well as those fields that inform and develop
the policies and laws that steer and regulate science, tech-
nology, and medicine as socio-public resources, services,
and good(s) [5,8,9]. In short, we argue that given the pace
of S/T progress, it will be vital to develop a cadre of profes-
sionals that are literate in science and equally cognizant of
the historicity of science and technology as elements that
can strongly shape, and are at the same time vulnerable to
the forces of culture. The requisite lens must view both
humanity and science as being dynamic, rather than static
or absolute [3], and in this way, afford perception that
scientific knowledge – and medicine – are not immune to
cultural beliefs, social norms, economics, and politics [10],
p.267-8. Such literacy is required for the “effective commu-
nication of scientific and technological findings…necessary
to make possible true public discussion of their ethical,
legal and social implications” [11], p.438. Hence, integra-
tion of ELSI into STEM and medical education serves two
goals: first, to engage non-science students to gain insight
(s) to scientific information necessary to appreciate and
analyze the social issues generated by the use of science
and technology in medicine to address perdurable prob-
lems of human health and human potential; and second, to
equip students in medicine and the biomedical sciences
with the philosophical, historical, and ethical knowledge to
foster insight to, and responsibility for, the ethical, legal,
and social aspects and impact of their work [12].Currently, both the United States’ National Science
Foundation (NSF) and the National Institutes of Health
(NIH) require training in the responsible conduct of
research (RCR, i.e., some form of research ethics) for all
students involved in projects and programs that are
pursuing or have been awarded (NSF or NIH) grant
funding [13,14]. Despite the NSF and NIH requirements
for RCR in STEM education, a recent survey of under-
graduate institutions revealed that only 37% of schools
included an ethics component in the core curriculum;
13% of the schools indicated that biology majors were
required to have (some) formal training in ethics, and
only a third of those required an ethics of science course
[15], indicating that training in research ethics has not
spread beyond those immediately impacted by the
mandate. It was also noted that the majority of instruc-
tors indicated that they spent less than 5% of lecture and
discussion time, if any, addressing ethical and social
issues in class [15]. Typical ethics courses and curricula
in medical schools provide a basic foundation of
concepts and clinical applications, and tend to function
under one of two main goals: either creating virtuous
physicians or giving physicians the skills and training to
analyze and resolve ethico-legal dilemmas [16]. While
these are reasonable goals, medical ethics training tends
to fall short of providing a more fine-grained explication
of those ways that science and technology can, have, and
will affect medical research and practice, the ELSI that can
be generated by this expanding capability and reliance
upon S/T advances in medicine, and the knowledge and
skill required to more genuinely and meaningfully address
the potential and problems fostered by the power of
this scientific and technological prowess to affect
human health, wellness, and suffering in and across
different cultures.
While NSF and NIH requirements stop short of mandat-
ing that institutions develop and provide full coursework to
all students in S/T majors – inclusive of medicine – we
maintain that such a dictate might in fact be defensible
(and laudable). This would establish both a defined neces-
sity for the purposeful conjoinment of ELSI-STEM, and do
so as a quid pro quo such that ethics education would be
required for potential and/or sustained funding of S/T re-
search. It is possible that the addition of ethics coursework
could be seen as a mere “check in the box” to secure on-
going fiscal support in the face of widespread university
and federal budgetary cuts. Even so, this can still be
seen as a plus-sum situation: if an adequate level of
NSF and/or NIH funding were to be provided to
support such ethics coursework (or curricula), appro-
priated monies could be used to re-fortify humanities’ pro-
grams that could be specifically designed to more
authentically and effectively inter-digitate with the sciences
and medicine.
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in, or a course on RCR is not, to our view, in and of
itself sufficient to meet either the full scope of NSF and
NIH intent, or, more specifically the idea and agenda of
In-STEPS as proposed herein. The importance of integrat-
ing ethics and policy into STEM education increases as S/T
innovation outpaces the development of policy and law. To
wit, the rate of scientific discovery and technological prod-
uct development has increased over the past two decades.
Using neuroscience and neurotechnology as an example, a
mean increase of 73% across sub-disciplines (e.g., various
forms of neuroimaging, neurogenetics, neuroproteomics,
neuroprosthetics, etc.) can be seen by assessing the indexed,
peer-reviewed literature of the past ten years [5]. As scien-
tific knowledge and technological capabilities expand, and
as such capabilities are possessed and exerted by a greater
number of nations with evermore diverse cultures, the
potential ethical, legal, and social issues that will arise – and
their implications – become more complex, intricate, and
challenging. Yet, as the speed of S/T progress and its trans-
lation into various aspects of medical diagnosis and treat-
ment has increased, the formulation of guidelines, policies,
and laws relevant to S/T research and use has slowed. Of
course, guideline formulation and policy-making are delib-
erative processes, designed for careful consideration and
durability of effect rather than for speed. It could be argued
that this slowing of dictates guiding the expansive advance-
ment and use of S/T innovation in clinical care reflect the
complexity of novel developments, in that more time is
required to accrue the information necessary to develop
sound policies to prudently guide such research and
its application(s). However, absent this consideration
is the reality that S/T development and use is reliant,
at least in part, upon guidelines and policies for sup-
port, sustenance, and direction. Thus, the dissonance
between S/T advancement and policy formulation may
result in much new medical S/T being unsupported,
unguided, and/or unregulated.
Ethics and biomedical science policy on the global stage
Knowledge about the process of politics is crucial as a
variety of private entities (e.g., commercial businesses,
venture capital investments) and political factions are
exerting increasing influence on standards, regulations,
and laws that bear upon the viability of the development
and use of biomedical S/T advances as public good(s)
[17]. In this regard, it is noteworthy that such S/T
research – and applications in medicine – are no longer
confined by national borders, and therefore, there is
need to address not only nations’ needs, values, and
mores, but the broader global dynamics that shape those
“contexts in which ethical norms and delineations of
human subjects are changing” [18], p.184. The constructs
and dictates of western philosophy and ethics mayno longer be considered as universally applicable or
appropriate to prescribe the conduct of S/T research
on the international scale, given that new biomedical
S/T enterprises—and a global economic presence—of
non-western nations, and commercial and cultural
groups are on the rise. It is becoming clear that vari-
ance in the cultural values, traditions, and ethical standards
between nations and regions can “… further entrench
inequality, justifying some interventions while disallowing
others” [18], p.184, and may prompt disequilibrium in the
ways that research in and employment(s) of biomedical S/T
advances are viewed, regarded, and engaged in global
economies, politics, and culture(s).
This diversity necessitates more than a mere superficial
appreciation, as there are risks of negatively bi-modal
ethical consequences if socio-cultural considerations are
less than thorough. On one hand there is the risk of
assuming an exclusively western ceteris paribus stance
and incurring frank ethical imperialism as western
precepts and standards are enforced (or perhaps more
accurately inflicted) upon other groups with dissimilar
needs, values, and norms. On the other hand, there is the
risk of treating any and all situations as prima facie
contingencies, and defaulting to laissez faire ethical rela-
tivism. Both cases pose a potential risk for exertion of
biopower and biopolitics [19]: the former via cultural
dominance and/or suppression, and the latter through a
form of locally constrictive, egoistic communitarianism
that might foster “look the other way” practices among
other nations and groups for the sake of ethical permis-
siveness and/or economic gain, and thereby permit what
might be viewed as (internal) violations of essential goods
and human rights [20]. It may be that some set of core
precepts could serve as a common morality to undergird
the conduct of biomedical S/T research and its use toward
the provision of social good [21]. But, how would such
“goods” be defined, and how are these definitions and the
practices they instantiate to be developed, and de-
cided upon, particularly when outcomes and products
of S/T research – and the practice of medicine – are
internationally and cross-culturally employed? To para-
phrase philosopher Alasdair MacIntyre: what good, which
justice, and whose rationalization [22]?
To be sure, any such bioethics must recognize cultural,
if not some level of moral plurality [23]. At very least,
some form of discursive ethics will be required to engage
the type of casuistic analysis necessary to appreciate and
navigate both socio-culturally-based moral variability,
and how this affects – and might be affected by – the
use of biomedical S/T advances upon the pluralist
terrain of the 21st century world stage [8]. If, in fact, the
“new global shift” produces what has been colloquially
described as a “flat world with creases” (i.e., highly access-
ible and interacting socio-economic cultural landscapes,
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and localized pockets of distinct power-identities of
smaller nations, groups, and individuals in diaspora)
then a more cosmopolitan bioethics that appreciates
anthropological constants and variation(s), and is sen-
sitive to standpoint, yet open to the dialectical formu-
lation of moral constructs, standards, and directions
will be needed [5,8,9,23-25].
Toward a vision - and plan - forward
The goal will be to establish an educational system – if
not paradigm – that will develop, enable, and empower
actors upon the new world stage who will be able to
direct the use of S/T innovation through an understand-
ing of both science, and “…principles which represent
the full moral experience and concerns of real human
beings” [26], p.18. In many ways, we believe that this
directly addresses 1) concerns about the widening
schism between science and the humanities [27], 2) the
ongoing debate about the validity and value of ethical
expertise in directing the scope and tenor of science and
technology (see, for example Selinger and Crease 2006
[28], for overview), and 3) a tendency toward overt
neo-scientism, technophilia and/or technocentricism
that fails to appreciate “real world” circumstances of
human ecology and culture that are affected by—and
concomitantly affect—the conduct, use, and potential
misuse of science, technology, and medicine [29-32].
In overview, this integrated system would progressively
weave historicity, ethics, and policy studies into STEM
courses over the course of students’ educational career.
Early on, at the high school level, course content-specific
examples could and should be integrated into regular
class work. High school level curricula are generally
more prescribed than those at higher levels of education
and as such, integration would best be facilitated through
collaborative initiatives connecting STEM teachers with
those in the humanities. An increase in grant funding
from organizations such as NSF and NIH, or through
university outreach opportunities, would provide sub-
stantial support for such initiatives, particularly since
individual grants at this educational level are often
smaller in amount.
At the undergraduate, graduate, and medical school
levels, an In-STEPS curriculum could be supported in a
number of different ways. University funding should
support representatives of academic departments collab-
orating toward both the integration of ELSI into STEM
courses and STEM applications into classes in the
humanities. Similarly, ELSI should be integrated into
medical school curricula as an expansion of the current
ethical coursework and training. Increased grants from
NSF and NIH in scientific ethics education—as an
expansion of funding programs that support the currentRCR initiatives—should support the development of new
interdisciplinary seminars group-taught by professors in
multiple departments and schools so as to guide
study of the reciprocity of STEM and ELSI; such
interdisciplinary courses could also access funding
sources in the humanities, thereby enhancing overall
fiscal support as well. Combined funding initiatives
that encourage collaboration between humanities and
STEM-related organizations would also facilitate inte-
gration in the professional realm and encourage the
bilateral translation of academic coursework to the
professional scenarios.
The effect(s) of such an In-STEPS paradigm extend
beyond the educational sphere to impact and encompass
the scope and tenor of interdisciplinary professional
development. Working within the In-STEPS approach, each
field would foster and encompass its own particular means
of integrating related STEM-ELSI issues. Opportunities
for trans-professional collaboration could be supported
through intra- and inter-organizational networking oppor-
tunities. By developing and sustaining cross-professional
relationships, consideration, and communication between
medicine, the sciences, engineering, and the humanities
can be focused both upon understanding how science and
technology offers—and provides—potential to improve
the human condition, as well as upon acknowledging and
bearing the responsibility to define, prevent, and/or miti-
gate the ethical, legal, and social burdens, risks, and harms
that such S/T advances might yield upon the current and
future world stage.Summary
Just as research is fostered, supported, and sustained
through the structure and function of the “triple helix”
conjoining academia, government, and private industry,
so too must be the educational training of future
biomedical professionals who will bear responsibility
for the effects that an ever-expanding fund of scien-
tific and biotechnological knowledge and capability
will yield upon the practice of medicine, humanity,
world culture, and global environments, writ both
small and large. These professionals must put to use
their integrated knowledge of the ethical, legal, and
social issues and how they work within and inform
the continued development and application of scien-
tific and technological advances in the medical diag-
noses and care. The model we propose is specifically
aimed at addressing this need, and our ongoing work
is dedicated to collaborating with multidisciplinary,
international colleagues and institutions to further
develop and realize the In-STEPS paradigm to affect
a more scientifically capable, yet sustainably humanitarian,
ethos and telos of medicine.
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